
Let's take a look at the next generation of pharmacotherapies for mood and anxiety disorders.
Ms King is a prospective neuroscience PhD student currently working as a postbaccalaureate research fellow at the Yale Depression Research Program. She is involved in clinical research on treatment-resistant depression, including studies comparing esketamine and IV ketamine, and gaining exposure to procedural interventions such as ECT and TMS.

Let's take a look at the next generation of pharmacotherapies for mood and anxiety disorders.